Recent Research Articles
A cancer prevention moonshot is nowhere on the horizon. Cancer is given chance after chance after chance. The worst part? Cancer is an insatiable opportunist.
We met, in 1992, after my local hematologist had the presence of mind to send me to an academic expert for a second opinion. At the time, Lee was considered one of the country’s top physician-investigator experts for CLL, and had recently made full professor at Harvard Medical School—a rarity for a 43-year-old.
Prior to my diagnosis 30 years ago I was a hard-core carnivore, with no desire to change. I ate whatever and whenever I liked. And though I enjoyed broccoli with my steak, my go-to veggie staples were French fries and ketchup.
Adequate sleep is vital for a healthy immune system. Short sleep and insomnia contribute to poor health—and may play a significant role in the onset of cancer. Learn what the science tells us about sleep and cancer, and 19 things we can do NOW to get more quality ZZZs.
Advanced cancer care is the cornerstone of integrative oncology. Without conventional care, integrative oncology and lifestyle modifications are not complete. Here are the latest advances in cancer care during 2020.
Compelling new study indicates that the time of day we participate in physical activity can help fend off cancer.
Does the published research on keto and fasting support this novel approach as a plausible standard of care to improve conventional therapy and reduce its often deleterious side effects?
A Clinician’s Perspective on Antioxidant Use During Chemotherapy for Breast Cancer: Exploring the Evidence
Master herbalist and clinical nutritionist Donnie Yance explores the research and shares his perspective on the use of botanicals and antioxidants during chemotherapy treatment for those with breast cancer.
Listen to Glenn Sabin interviewed on the influential Relentless Health Value podcast on the topic of integrative oncology in hospital and health system settings. Host Stacey Richter and Glenn discuss the growing science supporting integrative oncology and the profound opportunity for hospitals and cancer centers to engage and educate their communities on true cancer prevention focused on smart lifestyle—read: beyond vaccines, colonoscopies, mammograms and early detection.
There is good news in the advancement of chemo-free approaches to managing chronic lymphocytic leukemia, and I am thrilled to share it with you. Results of the phase III ECOG trial found that the combination of ibrutinib (Imbruvica) plus rituximab (Rituxan) came out superior to the chemotherapy and immunotherapy (chemoimmunotherapy) grouping of fludarabine, cyclophosphamide, and rituximab, known as FCR.